Nepal to administer second dose of Covid-19 vaccine from April 20

Nepal will administer the second dose of the Covid-19 vaccine from April 20 to April 28 to those who have received the first shot of the vaccine from January 27 and February 12.

vaccine, vaccination, coronavirus, covid
ANI Asia
2 min read Last Updated : Mar 07 2021 | 8:02 AM IST

Nepal will administer the second dose of the COVID-19 vaccine from April 20 to April 28 to those who have received the first shot of the vaccine from January 27 and February 12.

"The second dose of coronavirus vaccine for those who had received the first shot of ''Covishield'' between January 27 and February 12 will be administered from April 20 to April 28," The Himalayan Times reported citing Samir Kumar Adhikari, assistant spokesperson for the Ministry of Health and Population.

The first dose of the Covishield vaccine was given to health professionals, security personnel, officials of diplomatic missions, embassies, and those working in the United Nations.

On March 3, members of Nepal Parliament were administered the first jab of India-made COVID-19 vaccine at Minbhawan based Civil Hospital in Kathmandu.

According to the health ministry, 429,705 persons have received the first dose of the vaccine, which is 1.4 per cent of the total population.

Nepal last month received the second shipment of one million doses of the coronavirus vaccines from India.

Covishield, developed by AstraZeneca and Oxford University, is being manufactured by the Serum Institute of India (SII).

The second lot of vaccines would be used to inoculate people above 60 years of age, which is 8.73 per cent of Nepal's population in the vaccination drive that will begin on March 7.

Nepal began its nationwide inoculation drive after receiving the first one million Covishield vaccines following the emergency use approval in January.

India, under the Vaccine Maitri initiative, has been providing coronavirus vaccines to neighbouring countries.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Mar 07 2021 | 7:59 AM IST

Next Story